Brief: Rosetta Genomics says on track to launch novel thyroid cancer assay by Q3 end
26/02/2015 13:25
Feb 26 (Reuters) - Rosetta Genomics Ltd ROSG.O : * Says remains on track to launch the novel assay by the end of the third quarter of 2015 * Says its thyroid cancer assay moves to advanced stages of development * Source text for Eikon ID:nBw5WS1Fa * Further company coverage ROSG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics